Literature DB >> 13356174

Management of nephrosis; the use of long continued hormone therapy.

C F PIEL.   

Abstract

The course of nephrosis in 36 children was evaluated. Twelve of 24 who received no treatment or short-term courses of steroids died. Eleven of the 24 had been well for six months to five years at the time of this report. Twelve patients received steroids by schedule over extended periods. One died and eleven had been free of signs and symptoms of nephrosis for four to eighteen months at the time of report. In only two cases was therapy discontinued. It seems evident that these patients are experiencing a better state of well-being. Whether or not the prognosis is being altered for any single patient cannot be determined.

Entities:  

Keywords:  ACTH/therapeutic use; NEPHROSIS/in infant and child

Mesh:

Substances:

Year:  1956        PMID: 13356174      PMCID: PMC1531946     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  20 in total

1.  Problems of electrolyte and water balance in nephrotic syndrome.

Authors:  J A LUETSCHER
Journal:  AMA Arch Intern Med       Date:  1955-03

2.  Use of malaria therapy in the nephrotic syndrome.

Authors:  A S GILBERTSEN; F BASHOUR
Journal:  J Am Med Assoc       Date:  1956-01-07

3.  Treatment of the nephrotic syndrome in children.

Authors:  C P RANCE; A L CHUTE
Journal:  Can Med Assoc J       Date:  1955-12-15       Impact factor: 8.262

4.  Prolonged intermittent ACTH and cortisone therapy in the nephrotic syndrome; immunologic gasis and results.

Authors:  K LANGE; L SLOBODY; R STRANG
Journal:  Pediatrics       Date:  1955-02       Impact factor: 7.124

5.  Effects of infusion of hyperoncotic dextran in children with the nephrotic syndrome.

Authors:  J JAMES; G GORDILLO; J METCOFF
Journal:  J Clin Invest       Date:  1954-10       Impact factor: 14.808

6.  Corticotropin and cortisone in management of the nephrotic syndrome in children.

Authors:  C M RILEY
Journal:  J Am Med Assoc       Date:  1952-11-29

7.  Dextran for nephrotic edema; clinical experience.

Authors:  J T OLIVE; S D MILLS; J S LUNDY
Journal:  Proc Staff Meet Mayo Clin       Date:  1953-04-08

8.  Nephrotic syndrome in children; observations on the clinical course and the influence of sulfonamide and antibiotic therapy.

Authors:  I PHILIPS; J K CALVIN; B M KAGAN
Journal:  AMA Am J Dis Child       Date:  1953-04

9.  Effect of corticotropin (ACTH) on glomerular permeability to albumin and on blood antidiuretic hormone concentration in children with the nephrotic syndrome.

Authors:  H D LAUSON; C W FORMAN; H McNAMARA; G MATTAR; H L BARNETT
Journal:  AMA Am J Dis Child       Date:  1952-01

10.  Nephrotic syndrome in rats.

Authors:  W HEYMANN; H Z LUND
Journal:  Pediatrics       Date:  1951-05       Impact factor: 7.124

View more
  4 in total

Review 1.  The renaissance of corticotropin therapy in proteinuric nephropathies.

Authors:  Rujun Gong
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

Review 2.  Leveraging melanocortin pathways to treat glomerular diseases.

Authors:  Rujun Gong
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

Review 3.  How immunosuppressive drugs may directly target podocytes in glomerular diseases.

Authors:  Maurizio Salvadori; Aris Tsalouchos
Journal:  Pediatr Nephrol       Date:  2021-07-09       Impact factor: 3.651

4.  MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy.

Authors:  Yingjin Qiao; Anna-Lena Berg; Pei Wang; Yan Ge; Songxia Quan; Sijie Zhou; Hai Wang; Zhangsuo Liu; Rujun Gong
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.